Clinical trial
Combination Chemotherapy Plus Dexrazoxane in Treating Patients With Newly…
NCT00003937 · Children's Oncology Group, Other · Completed
Key facts
| NCT number | NCT00003937 |
|---|---|
| Title | Combination Chemotherapy Plus Dexrazoxane in Treating Patients With Newly Diagnosed Nonmetastatic Osteosarcoma |
| Official title | Protocol for Patients With Newly-Diagnosed Non-Metastatic Osteosarcoma - A POG/CCG Pilot Intergroup Study |
| Lead sponsor | Children's Oncology Group, Other |
| Collaborators | National Cancer Institute (NCI) NIH |
| Status | Completed |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Cardiac Toxicity, Sarcoma |
| Intervention type | Drug, Procedure |
| Interventions | cisplatin, dexrazoxane hydrochloride, doxorubicin hydrochloride, etoposide, ifosfamide, methotrexate, conventional surgery |
| Enrollment | 253 |
| Start date | Sep 1, 1999 |
| Primary completion | Mar 1, 2004 |
| Completion | Jun 1, 2008 |
| First posted | Feb 9, 2004 |
| Last update posted | Aug 5, 2014 |
| Countries | Australia, Canada, Netherlands, Puerto Rico, Switzerland, United States |
At a glance
- 100–999 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: